Format

Send to

Choose Destination
J Clin Lipidol. 2015 Nov-Dec;9(6 Suppl):S1-122.e1. doi: 10.1016/j.jacl.2015.09.002. Epub 2015 Sep 18.

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2.

Author information

1
Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA. Electronic address: tjaco02@emory.edu.
2
Midwest Center for Metabolic & Cardiovascular Research and DePaul University, Chicago, IL, USA.
3
University of Miami Miller School of Medicine, Miami, FL, USA.
4
Baylor College of Medicine, Houston, TX, USA.
5
Pennsylvania State University, Nutrition Department, State College, PA, USA.
6
University of California Irvine School of Medicine, Irvine, CA, USA.
7
Department of Medicine, Duke University, Durham, NC, USA.
8
University of Colorado School of Medicine, Aurora, CO, USA.
9
Cook Children's Medical Center, Fort Worth, TX, USA.
10
Medical University of South Carolina, Charleston, SC, USA.
11
Oklahoma University Health Sciences Center, Oklahoma City, OK, USA.
12
The University of Texas Southwestern Medical Center, Dallas, TX, USA.
13
University of Illinois College of Medicine, Chicago, IL, USA.
14
Tulane University School of Medicine, New Orleans, LA, USA.
15
Scottsdale Cardiovascular Center, Scottsdale, AZ, USA.
16
University of California San Francisco School of Medicine, San Francisco, CA, USA.
17
Icahn School of Medicine at Mount Sinai, New York, NY, USA.
18
Harvard Medical School, Cambridge, MA, USA.
19
Virginia Commonwealth University and National Clinical Research, Richmond, VA, USA.
20
University of Pennsylvania Health System, Philadelphia, PA, USA.
21
Rush University College of Nursing, Chicago, IL, USA.
22
Oregon State University/Oregon Health & Science University, College of Pharmacy, Portland, OR, USA.
23
Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY, USA.
24
Emory University School of Medicine, Atlanta, GA, USA.

Erratum in

  • J Clin Lipidol. 2016 Jan-Feb;10(1):211. Underberg, James A [added].

Abstract

An Expert Panel convened by the National Lipid Association previously developed a consensus set of recommendations for the patient-centered management of dyslipidemia in clinical medicine (part 1). These were guided by the principle that reducing elevated levels of atherogenic cholesterol (non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol) reduces the risk for atherosclerotic cardiovascular disease. This document represents a continuation of the National Lipid Association recommendations developed by a diverse panel of experts who examined the evidence base and provided recommendations regarding the following topics: (1) lifestyle therapies; (2) groups with special considerations, including children and adolescents, women, older patients, certain ethnic and racial groups, patients infected with human immunodeficiency virus, patients with rheumatoid arthritis, and patients with residual risk despite statin and lifestyle therapies; and (3) strategies to improve patient outcomes by increasing adherence and using team-based collaborative care.

KEYWORDS:

Adherence; Children; Clinical recommendations; Dyslipidemia; Elderly; Human immunodeficiency virus; Lifestyle therapies; Residual risk; Rheumatoid arthritis; Team-based care

PMID:
26699442
DOI:
10.1016/j.jacl.2015.09.002
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center